Cargando…
CD24 blunts the sensitivity of retinoblastoma to vincristine by modulating autophagy
Retinoblastoma (RB) is the most common childhood malignant intraocular tumor. The clinical efficacy of vincristine (VCR) in the treatment of RB is severely limited by drug resistance. Here, we found that CD24, a GPI‐anchored protein, was overexpressed in human RB tissues and RB cell lines, and was a...
Autores principales: | Sun, Jie, Feng, Dongju, Xi, Huiyu, Luo, Jiajing, Zhou, Zewei, Liu, Qinghuai, Chen, Yun, Shao, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400807/ https://www.ncbi.nlm.nih.gov/pubmed/32394616 http://dx.doi.org/10.1002/1878-0261.12708 |
Ejemplares similares
-
Effects of matrine on the proliferation and apoptosis of vincristine-resistant retinoblastoma cells
por: Zhao, Bowen, et al.
Publicado: (2020) -
Clinical Value of CD24 Expression in Retinoblastoma
por: Li, Jia, et al.
Publicado: (2012) -
Combined Treatment with an Oncolytic Adenovirus and Antitumor Activity of Vincristine against Retinoblastoma Cells
por: Song, Xin, et al.
Publicado: (2012) -
Correlation of CD24 expression with histological grading and TNM staging of retinoblastoma
por: Ishaq, Syed Muhammad, et al.
Publicado: (2016) -
Identification of small molecules that mitigate vincristine‐induced neurotoxicity while sensitizing leukemia cells to vincristine
por: Diouf, Barthelemy, et al.
Publicado: (2021)